1013 NKG2A expression on tumor reactive CD8 T cells is induced by IL-12 by Thomas Duhen, Venkatesh Rajamanickam, Jianguo Huang, Olivier Fesneau, Wesley Rosales, Kimberly Samson, William Haugh

IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells by Olivier Fesneau, Kimberly A. Samson, Wesley Rosales, Bretton Jones, Tarsem Moudgil, Bernard A. Fox, Venkatesh Rajamanickam, Thomas Duhen

Get full text

Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help by Terry R. Medler, Gwen Kramer, Shelly Bambina, Andrew J. Gunderson, Alejandro Alice, Tiffany Blair, Lauren Zebertavage, Thomas Duhen, Rebekka Duhen, Kristina Young, Marka R. Crittenden, Michael J. Gough

Get full text

MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response by Christophe Caux, Olivier Tredan, Thomas Duhen, Christine Ménétrier-Caux, Raphael Schneider, Laurie Besson, Isabelle Treilleux, Yenkel Grinberg-Bleyer, Anthony Di Roio, Margaux Hubert, Marion Bossennec, Céline Rodriguez, Guilhem Lalle, Lyvia Moudombi, Cyril Degletagne, Daniel J Campbell, Séverine Metzger

Get full text

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden by Sjoerd H van der Burg, Rebekka Duhen, Thomas Duhen, Marieke E Ijsselsteijn, Ruud van der Breggen, Koen C M J Peeters, Noel F C C de Miranda, Els M E Verdegaal, Dina Ruano, Manon van der Ploeg, Jitske van den Bulk, Arantza Fariña-Sarasqueta

Get full text